Loading chat...
OH SB230
Bill
Status
9/17/2014
Primary Sponsor
Nickie Antonio
Click for details
AI Summary
-
Removes the requirement that the Executive Director of the State Board of Pharmacy must be a licensed pharmacist in good standing in the practice of pharmacy in Ohio.
-
Prohibits pharmacists and pharmacy interns from directly delivering non-self-injectable cancer drugs to patients, their representatives, or their private residences.
-
Allows exceptions to the delivery prohibition if the private residence is a nursing home, residential care facility, rehabilitation facility, or similar healthcare facility.
-
Permits delivery to private residences of hospice patients or home health agency clients when a hospice employee or home health agency employee will administer the drug, with proper notification to the pharmacist.
-
Establishes separate notification requirements for minor patients in hospice or home health agency care, requiring notification from either the prescriber or the patient's parent/guardian/caregiver.
Legislative Description
To change the requirements to serve as the Executive Director of the State Board of Pharmacy and to establish standards for the delivery of non-self-injectable cancer drugs.
Non-self-injectable cancer drugs- establish standards for delivery of
Last Action
Effective Date
9/17/2014